628 related articles for article (PubMed ID: 34798898)
1. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic depletion of CCR8
Van Damme H; Dombrecht B; Kiss M; Roose H; Allen E; Van Overmeire E; Kancheva D; Martens L; Murgaski A; Bardet PMR; Blancke G; Jans M; Bolli E; Martins MS; Elkrim Y; Dooley J; Boon L; Schwarze JK; Tacke F; Movahedi K; Vandamme N; Neyns B; Ocak S; Scheyltjens I; Vereecke L; Nana FA; Merchiers P; Laoui D; Van Ginderachter JA
J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589525
[TBL] [Abstract][Full Text] [Related]
3. Lactic acid promotes PD-1 expression in regulatory T cells in highly glycolytic tumor microenvironments.
Kumagai S; Koyama S; Itahashi K; Tanegashima T; Lin YT; Togashi Y; Kamada T; Irie T; Okumura G; Kono H; Ito D; Fujii R; Watanabe S; Sai A; Fukuoka S; Sugiyama E; Watanabe G; Owari T; Nishinakamura H; Sugiyama D; Maeda Y; Kawazoe A; Yukami H; Chida K; Ohara Y; Yoshida T; Shinno Y; Takeyasu Y; Shirasawa M; Nakama K; Aokage K; Suzuki J; Ishii G; Kuwata T; Sakamoto N; Kawazu M; Ueno T; Mori T; Yamazaki N; Tsuboi M; Yatabe Y; Kinoshita T; Doi T; Shitara K; Mano H; Nishikawa H
Cancer Cell; 2022 Feb; 40(2):201-218.e9. PubMed ID: 35090594
[TBL] [Abstract][Full Text] [Related]
4. Bcl6 Preserves the Suppressive Function of Regulatory T Cells During Tumorigenesis.
Li Y; Wang Z; Lin H; Wang L; Chen X; Liu Q; Zuo Q; Hu J; Wang H; Guo J; Xie L; Tang J; Li Z; Hu L; Xu L; Zhou X; Ye L; Huang Q; Xu L
Front Immunol; 2020; 11():806. PubMed ID: 32477338
[TBL] [Abstract][Full Text] [Related]
5. Curcumin analog GO-Y030 boosts the efficacy of anti-PD-1 cancer immunotherapy.
MaruYama T; Kobayashi S; Shibata H; Chen W; Owada Y
Cancer Sci; 2021 Dec; 112(12):4844-4852. PubMed ID: 34529884
[TBL] [Abstract][Full Text] [Related]
6. Anti-PD-1 Checkpoint Therapy Can Promote the Function and Survival of Regulatory T Cells.
Vick SC; Kolupaev OV; Perou CM; Serody JS
J Immunol; 2021 Nov; 207(10):2598-2607. PubMed ID: 34607937
[TBL] [Abstract][Full Text] [Related]
7. Sunitinib Exerts
Ocadlikova D; Lecciso M; Broto JM; Scotlandi K; Cavo M; Curti A; Palmerini E
Front Immunol; 2021; 12():577766. PubMed ID: 33717062
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of the adenosine A2a receptor modulates expression of T cell coinhibitory receptors and improves effector function for enhanced checkpoint blockade and ACT in murine cancer models.
Leone RD; Sun IM; Oh MH; Sun IH; Wen J; Englert J; Powell JD
Cancer Immunol Immunother; 2018 Aug; 67(8):1271-1284. PubMed ID: 29923026
[TBL] [Abstract][Full Text] [Related]
9. Caloric Restriction Impairs Regulatory T cells Within the Tumor Microenvironment After Radiation and Primes Effector T cells.
Manukian G; Kivolowitz C; DeAngelis T; Shastri AA; Savage JE; Camphausen K; Rodeck U; Zarif JC; Simone NL
Int J Radiat Oncol Biol Phys; 2021 Aug; 110(5):1341-1349. PubMed ID: 33647370
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic DNA vaccine targeting Foxp3
Namdar A; Mirzaei R; Memarnejadian A; Boghosian R; Samadi M; Mirzaei HR; Farajifard H; Zavar M; Azadmanesh K; Elahi S; Noorbakhsh F; Rezaei A; Hadjati J
Cancer Immunol Immunother; 2018 Mar; 67(3):367-379. PubMed ID: 29124314
[TBL] [Abstract][Full Text] [Related]
11. Lineage Reprogramming of Effector Regulatory T Cells in Cancer.
Dixon ML; Leavenworth JD; Leavenworth JW
Front Immunol; 2021; 12():717421. PubMed ID: 34394124
[TBL] [Abstract][Full Text] [Related]
12. Antitumor CD8 T cell responses in glioma patients are effectively suppressed by T follicular regulatory cells.
Lu L; Sun J; Su H; Luo S; Chen J; Qiu S; Chi Y; Lin J; Xu X; Zheng D
Exp Cell Res; 2021 Oct; 407(2):112808. PubMed ID: 34508744
[TBL] [Abstract][Full Text] [Related]
13. Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis.
Delgoffe GM; Woo SR; Turnis ME; Gravano DM; Guy C; Overacre AE; Bettini ML; Vogel P; Finkelstein D; Bonnevier J; Workman CJ; Vignali DA
Nature; 2013 Sep; 501(7466):252-6. PubMed ID: 23913274
[TBL] [Abstract][Full Text] [Related]
14. Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas.
Amoozgar Z; Kloepper J; Ren J; Tay RE; Kazer SW; Kiner E; Krishnan S; Posada JM; Ghosh M; Mamessier E; Wong C; Ferraro GB; Batista A; Wang N; Badeaux M; Roberge S; Xu L; Huang P; Shalek AK; Fukumura D; Kim HJ; Jain RK
Nat Commun; 2021 May; 12(1):2582. PubMed ID: 33976133
[TBL] [Abstract][Full Text] [Related]
15. MHC Class II Antigen Presentation by Lymphatic Endothelial Cells in Tumors Promotes Intratumoral Regulatory T cell-Suppressive Functions.
Gkountidi AO; Garnier L; Dubrot J; Angelillo J; Harlé G; Brighouse D; Wrobel LJ; Pick R; Scheiermann C; Swartz MA; Hugues S
Cancer Immunol Res; 2021 Jul; 9(7):748-764. PubMed ID: 33952631
[TBL] [Abstract][Full Text] [Related]
16. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780
[TBL] [Abstract][Full Text] [Related]
17. The Curcumin Analog GO-Y030 Controls the Generation and Stability of Regulatory T Cells.
MaruYama T; Kobayashi S; Nakatsukasa H; Moritoki Y; Taguchi D; Sunagawa Y; Morimoto T; Asao A; Jin W; Owada Y; Ishii N; Iwabuchi Y; Yoshimura A; Chen W; Shibata H
Front Immunol; 2021; 12():687669. PubMed ID: 34248973
[TBL] [Abstract][Full Text] [Related]
18. Combination of ultrasound-based mechanical disruption of tumor with immune checkpoint blockade modifies tumor microenvironment and augments systemic antitumor immunity.
Abe S; Nagata H; Crosby EJ; Inoue Y; Kaneko K; Liu CX; Yang X; Wang T; Acharya CR; Agarwal P; Snyder J; Gwin W; Morse MA; Zhong P; Lyerly HK; Osada T
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35039461
[TBL] [Abstract][Full Text] [Related]
19. Peripheral CX3CR1
Li C; Zhang Z; Cai Q; Zhao Q; Wu H; Li J; Liu Y; Zhao X; Liu J; Ping Y; Shan J; Yang S; Zhang Y
Oncoimmunology; 2024; 13(1):2355684. PubMed ID: 38798746
[TBL] [Abstract][Full Text] [Related]
20. CD74 supports accumulation and function of regulatory T cells in tumors.
Bonnin E; Rodrigo Riestra M; Marziali F; Mena Osuna R; Denizeau J; Maurin M; Saez JJ; Jouve M; Bonté PE; Richer W; Nevo F; Lemoine S; Girard N; Lefevre M; Borcoman E; Vincent-Salomon A; Baulande S; Moreau HD; Sedlik C; Hivroz C; Lennon-Duménil AM; Tosello Boari J; Piaggio E
Nat Commun; 2024 May; 15(1):3749. PubMed ID: 38702311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]